Struggling with hyperphosphatemia in dialysis patients? 🦴🫘

Meet #Tenapanor!

It inhibits paracellular phosphate absorption by modulating NHE3 & tight junctions.

A novel way to tackle phosphorus! 🔬💊

#Nephrology #Hyperphosphatemia #Dialysis #HD

📖https://doi.org/10.1053/j.jrn.2024.07.003

Fosun Pharma's Tenapanor Hydrochloride Tablets Receives NMPA Approval for Dialysis Patients Fosun Pharma has received NMPA approval for Tenapanor Hydrochloride Tablets, an innovative treatment for dialysis patients with hyperphosphatemia in China.

Fosun Pharma's Tenapanor Hydrochloride Tablets Receives NMPA Approval for Dialysis Patients #China #Shanghai #NMPA #Fosun_Pharma #Tenapanor